E board review in Breast Cancer February 2008 Reading List
html>body {font-size: small;}a:link {color: #990000}a:visited {color: #990000;}a:hover {color: #cccccc}table td {padding: 0pt; border-width: 0; vertical-align: top; font-family: arial, helvetica, verdana, sans-serif;}td#footer {background: #ccffcc; padding: 10px; font: normal 90% arial, helvetica, sans-serif; vertical-align: middle;}td#sponsor a {color: #FFF;}td#sponsor a:visited {color: #FFF;}td#sponsor {background: #333399; width: 625px; height: 10px; padding: 5px; font: 100% verdana, arial, helvetica ; color: #ffffff;}td#date {background: #cccccc; width: 625px; height: 10px; padding: 5px 5px; font: bold 110% verdana, arial, helvetica ; color: #000000;}b#ge {font: italic bold 100% verdana, arial, helvetica;}td#content {font: normal 10pt/14pt arial, verdana, helvetica; padding: 5px;}h3 {font: bold 120% verdana, arial, helvetica, sans-seif; color: #000000; padding: 5px;}h4 {font: normal 120% verdana, arial, helvetica, sans-seif; color: #000000;}h5 {font: times,serif; color: #990000;}div#links {position: absolute; top: 40px left: 0; width: 200px;}div#links a {color: #ffcc00; display: block; padding: 5px 10px; margin: 0 0 2px; border-width=0; text-align: center; font: bold 17px/17px sans-serif; text-decoration: none;}div#links a:visited:hover {color: #cccccc;}a.bluelink:link, a.bluelink:visited { color:#036; font:normal 10px "Lucida Grande", "Lucida Sans Unicode", verdana, lucida, sans-serif; text-decoration :underline;}.menunav { border-top: 2px solid #5A6565; background: #919898; padding: 3px 3px 3px 3px; border-bottom: 2px solid #ffffff; }.menunav_selected { color: #FFFFFF;background: #B2B7B7; border-top: 2px solid #5A6565; padding: 3px 3px 3px 3px; border-bottom: 2px solid #ffffff; }.menunav_selected_sub { background: #D3D6D6; padding: 3px 3px 3px 15px; }div#menu_menu {width: 90%;border: 1px solid #333;padding: 10px 10px 0px 10px;}div#menu_menu a { padding: 3px 0 3px 0; border-top: 1px solid #990000; text-decoration: none;color:#000; font-family:arial, helvetica, sans-serif; font-size: x-small; display: block; text-align: left; vertical-align: bottom;}div#menu_menu a:hover {color: #FFFFFF;background: #990000;}#menu_menu LI { margin: 10; padding: 0; display: inline; border-bottom: 2px solid #ffffff; }div#apply {width: 100%;border: 0px solid #333;padding: 0px 0px 0px 0px;background: #008A45;}div#apply a { border-top: 1px solid #990000; text-decoration: none;color:#FFF0D0; font-family:arial, helvetica, sans-serif; font-size: x-small; display: block; text-align: left; vertical-align: bottom;}div#apply a:hover {color: #FFFFFF;background: #990000;}#apply LI { margin: 10; padding: 0; display: inline; border-bottom: 2px solid #ffffff; } #menurightcolumn { width: 220px; \width: 240px; w\idth: 220px; padding: 10px; text-align: left; margin: 0px; float: right; }.clearer {clear: both;}ol {list-style-type: decimal; margin-left:20px;}
Suggested Reading List
Reducing Risk/Increasing Survival
(Questions 1–7)
Adjuvant Therapy
(Questions 8–13)
Treatment Results
(Questions 14–20)
Advanced and Recurrent Disease
(Questions 21–32)
Breast Cancer Subtypes
(Questions 33–36)
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
